Board meeting scheduled for May 27, 2026, to approve audited financial results for H2 and year ended March 31, 2026.
Agenda includes consideration of final dividend for FY26 and re-appointment of Managing and Executive Directors.
Trading window closed until 48 hours after board meeting conclusion per insider trading regulations.